187 related articles for article (PubMed ID: 33629579)
1. Involvement of GPR30 in protection effect of Dexmedetomidine against myocardial ischemia/reperfusion injury in rat via AKT pathway.
Shao Z; Shen Q; Kong M; Ni H; Hou X
Acta Biochim Pol; 2021 Feb; 68(1):119-126. PubMed ID: 33629579
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
Chang JH; Jin MM; Liu JT
Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine Protects against Myocardial Ischemia/Reperfusion Injury by Ameliorating Oxidative Stress and Cell Apoptosis through the Trx1-Dependent Akt Pathway.
Wu ZL; Davis JRJ; Zhu Y
Biomed Res Int; 2020; 2020():8979270. PubMed ID: 33299886
[TBL] [Abstract][Full Text] [Related]
4. Urolithin A alleviates myocardial ischemia/reperfusion injury via PI3K/Akt pathway.
Tang L; Mo Y; Li Y; Zhong Y; He S; Zhang Y; Tang Y; Fu S; Wang X; Chen A
Biochem Biophys Res Commun; 2017 May; 486(3):774-780. PubMed ID: 28343995
[TBL] [Abstract][Full Text] [Related]
5. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
[TBL] [Abstract][Full Text] [Related]
6. Syringic acid mitigates myocardial ischemia reperfusion injury by activating the PI3K/Akt/GSK-3β signaling pathway.
Liu G; Zhang BF; Hu Q; Liu XP; Chen J
Biochem Biophys Res Commun; 2020 Oct; 531(2):242-249. PubMed ID: 32798018
[TBL] [Abstract][Full Text] [Related]
7. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
Zhang J; Jiang H; Liu DH; Wang GN
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
[TBL] [Abstract][Full Text] [Related]
8. Sodium tanshinone IIA sulfonate protects rat myocardium against ischemia-reperfusion injury via activation of PI3K/Akt/FOXO3A/Bim pathway.
Zhang MQ; Zheng YL; Chen H; Tu JF; Shen Y; Guo JP; Yang XH; Yuan SR; Chen LZ; Chai JJ; Lu JH; Zhai CL
Acta Pharmacol Sin; 2013 Nov; 34(11):1386-96. PubMed ID: 24077633
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism.
Riquelme JA; Westermeier F; Hall AR; Vicencio JM; Pedrozo Z; Ibacache M; Fuenzalida B; Sobrevia L; Davidson SM; Yellon DM; Sánchez G; Lavandero S
Pharmacol Res; 2016 Jan; 103():318-27. PubMed ID: 26607864
[TBL] [Abstract][Full Text] [Related]
10. The Protective Mechanism of Dexmedetomidine in Regulating Atg14L-Beclin1-Vps34 Complex Against Myocardial Ischemia-Reperfusion Injury.
Li Y; Qu M; Xing F; Li H; Cheng D; Xing N; Zhang W
J Cardiovasc Transl Res; 2021 Dec; 14(6):1063-1074. PubMed ID: 33914271
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol protects myocardial apoptosis induced by ischemia-reperfusion in rats with acute myocardial infarction via blocking P13K/Akt/e-NOS pathway.
Zhang X; Huang LF; Hua L; Feng HK; Shen B
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1789-1796. PubMed ID: 30840305
[TBL] [Abstract][Full Text] [Related]
12. Methyl palmitate protects heart against ischemia/reperfusion-induced injury through G-protein coupled receptor 40-mediated activation of the PI3K/AKT pathway.
Shen YJ; Shen YC; Lee WS; Yang KT
Eur J Pharmacol; 2021 Aug; 905():174183. PubMed ID: 34015318
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress.
Li J; Zhao Y; Zhou N; Li L; Li K
J Diabetes Res; 2019; 2019():7869318. PubMed ID: 31886285
[TBL] [Abstract][Full Text] [Related]
14. Shikonin protects H9C2 cardiomyocytes against hypoxia/reoxygenation injury through activation of PI3K/Akt signaling pathway.
Wang S; Zhu Y; Qiu R
Biomed Pharmacother; 2018 Aug; 104():712-717. PubMed ID: 29807220
[TBL] [Abstract][Full Text] [Related]
15. Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion.
Song JQ; Teng X; Cai Y; Tang CS; Qi YF
Apoptosis; 2009 Sep; 14(9):1061-9. PubMed ID: 19634012
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotection of tilianin ameliorates myocardial ischemia-reperfusion injury: Role of the apoptotic signaling pathway.
Zeng C; Jiang W; Zheng R; He C; Li J; Xing J
PLoS One; 2018; 13(3):e0193845. PubMed ID: 29538428
[TBL] [Abstract][Full Text] [Related]
17. Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion.
Fang F; Li D; Pan H; Chen D; Qi L; Zhang R; Sun H
Pharmacology; 2011; 88(3-4):149-58. PubMed ID: 21934351
[TBL] [Abstract][Full Text] [Related]
18. GYY4137 protects against myocardial ischemia/reperfusion injury via activation of the PHLPP-1/Akt/Nrf2 signaling pathway in diabetic mice.
Qiu Y; Wu Y; Meng M; Luo M; Zhao H; Sun H; Gao S
J Surg Res; 2018 May; 225():29-39. PubMed ID: 29605032
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of urantide against ischemia-reperfusion injury via protein kinase C and phosphtidylinositol 3'-kinase - Akt pathway.
Zhang JY; Chen ZW; Yao H
Can J Physiol Pharmacol; 2012 May; 90(5):637-45. PubMed ID: 22537485
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia-reperfusion injury by 3',4'-dihydroxyflavonol.
Thomas CJ; Lim NR; Kedikaetswe A; Yeap YY; Woodman OL; Ng DC; May CN
Eur J Pharmacol; 2015 Jul; 758():53-9. PubMed ID: 25820159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
